Mesoblast MESO
NASDAQ MESO
$12.55 -0.28 (-2.18%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mesoblast (MESO) Change in Other Operating Liabilities (2018 - 2020)

Updated

Analysis

Mesoblast (MESO) Change in Other Operating Liabilities (2018 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.69 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -112.00 Mn
10 Mesoblast 1.63 Bn 1.19 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -10.00 Mn
Sep 30, 2018 10.00 Mn
API Access

Mesoblast Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=MESO&period=max&api_key=YOUR_API_KEY